Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts. - Burke RM; Lighthouse JK; Mickelsen DM; Small EM (Circulation. Heart failure, 2019)